Interstitial Lung Disease (ILD) is an umbrella term for lung disorders characterised by tissue inflammation or scarring. Join our host Professor Robin Condliffe as he chats with Dr Nazia Chaudhuri to discuss the exciting developments in ILD treatment and the progress made by the registry team. Dr Chaudhuri is a respiratory physician with a specialist interest in the interstitial lung disease (ILD) service. She has published her experience in prescribing antifibrotics and delivering MDT care and has presented at all of the major respiratory conferences. She is chair of the British Thoracic Society (BTS) interstitial and rare lung disease specialist advisory group, which oversees the ILD registry.The views expressed by guests on this podcast are their own, and do not necessarily represent those of their employer or of Respiratory Futures or the British Thoracic Society. Follow us on social media to stay up to date with our activities. Websites: www.respiratoryfutures.org.uk, www.brit-thoracic.org.uk Bluesky and X: @respfutures, @BTSrespiratory LinkedIn: @BritishThoracicSociety

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related